SCHEMBL7767918

SCHEMBL7767918

COC(=O)c1cccnc1N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
MAPT P10636 1/20 0.53
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
FAAH O00519 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
MTOR P42345 1/20 0.52
RAB9A P51151 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
DRD3 P35462 7/20 0.50
DRD2 P14416 5/20 0.50
HTR2A P28223 5/20 0.50
ADRA1A P35348 5/20 0.50
HRH1 P35367 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7796036 0.99 LMNA (0.52) LMNAMAPTCYP3A4CYP2D6FAAH
Hydrochloric Acid SCHEMBL7920769 0.99 LMNA (0.52) LMNAMAPTCYP3A4CYP2D6FAAH
SCHEMBL7794410 0.91 LMNA (0.52) LMNAMAPTCYP3A4CYP2D6FAAH
SCHEMBL7773850 0.91 MAPT (0.67) LMNAMAPTCYP3A4CYP2D6FAAH
Hydrochloric Acid SCHEMBL7797695 0.90 MAPT (0.66) LMNAMAPTCYP3A4CYP2D6FAAH
Hydrochloric Acid SCHEMBL7794406 0.90 LMNA (0.51) LMNAMAPTCYP3A4CYP2D6FAAH
SCHEMBL7794415 0.89 DRD3 (0.53) LMNAMAPTCYP3A4CYP2D6FAAH
SCHEMBL7771969 0.88 LMNA (0.52) LMNAMAPTCYP3A4CYP2D6FAAH
Hydrochloric Acid SCHEMBL9602731 0.88 MEN1 (0.52) LMNAMAPTCYP3A4CYP2D6FAAH
Hydrochloric Acid SCHEMBL7794427 0.87 LMNA (0.51) LMNAMAPTCYP3A4CYP2D6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658910-A TREATING MENTAL DISORDERS PHARMACIA AB (SE) 1997-08-19 US claimed
EP-0673368-B1 NOVEL NICOTINIC ACID ESTERS BIOVITRUM AB (SE) 2001-11-28 EP disclosed
EP-1120410-A1 Nicotinic acid esters useful as CNS agents and having affinity for 5-HT receptors Pharmacia AB (SE) 2001-08-01 EP disclosed
US-6221858-B1 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders PHARMACIA & UPJOHN AB (SE) 2001-04-24 US disclosed
EP-0637242-B1 AGENTS FOR TREATING SUBSTANCE ABUSE DISORDERS PHARMACIA & UPJOHN AB (SE) 1999-09-15 EP disclosed
US-5658910-A TREATING MENTAL DISORDERS PHARMACIA AB (SE) 1997-08-19 US disclosed
US-5565455-A ADMINISTERING A BISPHENYLALKYLPIPERAZINE TO COMBAT WITHDRAWAL SYMPTOMS PHARMACIA AB (SE) 1996-10-15 US disclosed
EP-0673368-A1 NOVEL NICOTINIC ACID ESTERS Pharmacia & Upjohn Aktiebolag (SE) 1995-09-27 EP disclosed
EP-0637242-A1 AGENTS FOR TREATING SUBSTANCE ABUSE DISORDERS Kabi Pharmacia AB (SE) 1995-02-08 EP disclosed
WO-1994000434-A1 NOVEL NICOTINIC ACID ESTERS KABI PHARMACIA AB (SE) 1994-01-06 WO disclosed
WO-1993020821-A1 AGENTS FOR TREATING SUBSTANCE ABUSE DISORDERS KABI PHARMACIA AB (SE) 1993-10-28 WO disclosed